A tropism-modified adenoviral vector increased the effectiveness of gene therapy for arthritis

Gene Therapy

Volumn 8, Issue 23, 2001, Pages 1785-1793

  Bakker, A C ^a   Van De Loo, F A J ^a   Joosten, L A B ^a   Bennink, M B ^a   Arntz, O J ^a   Dmitriev, I P ^b   Kashentsera, E A ^b   Curiel, D T ^b   Van Den Berg, W B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Adenovirus; Arthritis; CIA; mCAR; RGD; Synovium

Indexed keywords

ADENOVIRUS VECTOR; ARGINYLGLYCYLASPARTIC ACID; CYTOKINE; INTEGRIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LUCIFERASE; VIRUS RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPORT; CLINICAL PROTOCOL; CONTROLLED STUDY; COXSACKIE VIRUS; DRUG EFFICACY; EXPERIMENTAL MODEL; GENE ACTIVITY; GENE OVEREXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; KNEE; MALE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN TARGETING; RHEUMATOID ARTHRITIS; SYNOVIUM; TREATMENT OUTCOME;

ADENOVIRIDAE; ANIMALS; ARTHRITIS, EXPERIMENTAL; GENE THERAPY; GENETIC VECTORS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; OLIGOPEPTIDES; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIALOGLYCOPROTEINS; SYNOVIAL MEMBRANE; TRANSDUCTION, GENETIC; TROPISM;

ADENOVIRIDAE; ANIMALIA; COXSACKIEVIRUS; DNA VIRUSES; MURINAE;

EID: 0035704117     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301612     Document Type: Article

References (36)

1. Gene therapy for rheumatic diseases
2. Gene transfer: From concept to therapy
3. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment
4. Multiple adenovirus serotypes use alpha v integrins for infection
5. Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells
6. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts
7. Infection efficiency of type 5 adenoviral vectors in synovial tissue can be enhanced with a type 16 fiber
8. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism
9. Adhesion receptors of intimal and subintimal cells of the normal synovial membrane
10. Differential expression and functional behaviour of the alpha v and beta 3 integrin subunits in cytokine stimulated fibroblast-like cells derived from synovial tissue of rheumatoid arthritis and osteoarthritis in vitro
11. Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis influence of disease duration and activity
12. Altered integrin expression in rheumatoid synovial lining type B cells: In vitro cytokine regulation of alpha 1 beta 1, alpha 6 beta 1, and alpha v beta 5 integrins
13. Localization of the alpha v subfamily of integrins and their putative ligands in synovial lining cell layer
14. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra
15. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation
16. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee
17. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction
18. RGD and other recognition sequences for integrins
19. Increased expression of integrins on fibroblast-like synoviocytes from rheumatoid arthritis in vitro correlates with enhanced binding to extracellular matrix proteins
20. Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid
21. Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens
22. Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity
23. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF, alpha anti-IL-1 alpha/beta, and IL-1Ra
24. Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector
25. Disease inducible IL-1Ra oerexpression results in a more efficient inhibition of the collagen induced arthritis model than constitutive overexpression of IL-1Ra
26. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism
27. Genetic capsid modifications allow efficient retargeting of adeno-associated virus type 2
28. Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody
29. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
30. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy
31. Methods for adenovirus-mediated gene transfer to airway epithelium
32. Quantification of mRNA levels in joint capsule and articular cartilage of the murine knee joint by RT-PCR: Kinetics of stromelysin and IL-1 mRNA levels during arthritis
33. Enzyme histochemical reactions in unfixed and undecalcified cryostat sections of mouse knee joints with special reference to artritic lesions
34. Streptococcal cell wall-induced arthritis and flare-up reaction in mice induced by homologous or heterologous cell walls
35. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction
36. Electrical charge of the antigen determines intra-articular antigen handling and chronicity of arthritis in mice